1. Home
  2. TVRD vs DENN Comparison

TVRD vs DENN Comparison

Compare TVRD & DENN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVRD
  • DENN
  • Stock Information
  • Founded
  • TVRD 2017
  • DENN 1953
  • Country
  • TVRD United States
  • DENN United States
  • Employees
  • TVRD N/A
  • DENN N/A
  • Industry
  • TVRD Biotechnology: Pharmaceutical Preparations
  • DENN Restaurants
  • Sector
  • TVRD Health Care
  • DENN Consumer Discretionary
  • Exchange
  • TVRD Nasdaq
  • DENN Nasdaq
  • Market Cap
  • TVRD 246.5M
  • DENN 203.4M
  • IPO Year
  • TVRD N/A
  • DENN 1989
  • Fundamental
  • Price
  • TVRD $28.34
  • DENN $3.82
  • Analyst Decision
  • TVRD Strong Buy
  • DENN Strong Buy
  • Analyst Count
  • TVRD 2
  • DENN 6
  • Target Price
  • TVRD $52.00
  • DENN $7.46
  • AVG Volume (30 Days)
  • TVRD 48.4K
  • DENN 850.5K
  • Earning Date
  • TVRD 05-13-2025
  • DENN 05-05-2025
  • Dividend Yield
  • TVRD N/A
  • DENN N/A
  • EPS Growth
  • TVRD N/A
  • DENN N/A
  • EPS
  • TVRD N/A
  • DENN 0.33
  • Revenue
  • TVRD N/A
  • DENN $453,997,000.00
  • Revenue This Year
  • TVRD N/A
  • DENN $7.51
  • Revenue Next Year
  • TVRD N/A
  • DENN $1.98
  • P/E Ratio
  • TVRD N/A
  • DENN $11.61
  • Revenue Growth
  • TVRD N/A
  • DENN N/A
  • 52 Week Low
  • TVRD $8.13
  • DENN $2.85
  • 52 Week High
  • TVRD $34.31
  • DENN $7.73
  • Technical
  • Relative Strength Index (RSI)
  • TVRD N/A
  • DENN 46.49
  • Support Level
  • TVRD N/A
  • DENN $3.63
  • Resistance Level
  • TVRD N/A
  • DENN $4.13
  • Average True Range (ATR)
  • TVRD 0.00
  • DENN 0.19
  • MACD
  • TVRD 0.00
  • DENN -0.05
  • Stochastic Oscillator
  • TVRD 0.00
  • DENN 16.96

About TVRD Tvardi Therapeutics Inc. Common Stock

Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases. Its key product candidate, TTI-101, is in Phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC). Its second product candidate, TTI-109, is structurally related to, yet chemically distinct from, TTI-101 and is designed to enhance the ability to target STAT3.

About DENN Denny's Corporation

Denny's Corp is one of America's franchised full-service restaurant chains based on the number of restaurants. The company owns and operates the Denny's brand and the Keke's Breakfast Cafe brand. It provides Pancakes, Appetizers & Soups, Sandwiches & Salads, Breakfast Melts, Omelets, and others. The company generates its revenue from two sources: the sale of food and beverages and the collection of royalties, advertising revenue, initial and other fees, including occupancy revenue, from restaurants operated by their franchisees.

Share on Social Networks: